Europe Endorses Its First mRNA Vaccine for RSV

Source link :

The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorization for the mRNA respiratory syncytial virus (RSV) vaccine mRESVIA (mRNA-1345) to protect adults aged 60 years or older from lower respiratory tract disease caused by RSV infection. RSV is a highly contagious seasonal respiratory virus and […]

Author : News Health

Publish date : 2024-06-28 17:34:07

Copyright for syndicated content belongs to the linked Source.